Systemic Glucocorticoid Treatment for Cutaneous Rosai-Dorfman Disease Affecting the Left Ear: A Case Study

• by Xiaoxue Zhuo, Zhuoma Dangzeng, Peiyu Zhou, Tingting Wang, Lin Wang

• April 21, 2026

FDA approves oral dermatomyositis therapy

Phase 3 findings show improvements in physical function and skin disease activity.

• by Kathryn Wighton

• August 28, 2026

• 2 min

High progesterone may be tied to syringoma

Elevated levels occurred in 29% of women with the condition compared with 6% of controls in a cross-sectional study.

• by Andrea Surnit

• August 31, 2026

• 3 min

The Circadian Skin: Chronobiology as a New Frontier in Dermatological Therapy

• by Diala Haykal

• September 7, 2026